What is the share price of Influx Healthtech Ltd (INFLUX) today?
The share price of INFLUX as on 12th November 2025 is ₹188.65. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Influx Healthtech Ltd (INFLUX) share?
The past returns of Influx Healthtech Ltd (INFLUX) share are- Past 1 week: -8.55%
- Past 1 month: 7.60%
- Past 3 months: 30.64%
- Past 6 months: 49.48%
- Past 1 year: 49.48%
- Past 3 years: N/A%
- Past 5 years: 49.48%
What are the peers or stocks similar to Influx Healthtech Ltd (INFLUX)?
The peers or stocks similar to Influx Healthtech Ltd (INFLUX) include:What is the market cap of Influx Healthtech Ltd (INFLUX) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Influx Healthtech Ltd (INFLUX) is ₹436.73 Cr as of 12th November 2025.What is the 52 week high and low of Influx Healthtech Ltd (INFLUX) share?
The 52-week high of Influx Healthtech Ltd (INFLUX) is ₹208 and the 52-week low is ₹120.What is the PE and PB ratio of Influx Healthtech Ltd (INFLUX) stock?
The P/E (price-to-earnings) ratio of Influx Healthtech Ltd (INFLUX) is 32.69. The P/B (price-to-book) ratio is 12.08.Which sector does Influx Healthtech Ltd (INFLUX) belong to?
Influx Healthtech Ltd (INFLUX) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Influx Healthtech Ltd (INFLUX) shares?
You can directly buy Influx Healthtech Ltd (INFLUX) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Influx Healthtech Ltd
INFLUX Share Price
188.654.98% (+8.95)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
INFLUX Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
INFLUX Performance & Key Metrics
INFLUX Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 12.08 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.59% |
INFLUX Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
INFLUX Company Profile
Influx Healthtech Ltd is a contract development and manufacturing organization producing dietary supplements, cosmetics, ayurvedic formulations, veterinary feed supplements, and pharmaceutical dosage forms in India.
SUNPHARMA
PE Ratio
38.03
38.03
1Y Return
3.82%
3.82%
Buy Reco %
91.43
91.43
TORNTPHARM
PE Ratio
67.73
67.73
1Y Return
21.38%
21.38%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.28
23.28
1Y Return
0.38%
0.38%
Buy Reco %
67.74
67.74
DRREDDY
PE Ratio
18.10
18.10
1Y Return
2.71%
2.71%
Buy Reco %
41.94
41.94
ZYDUSLIFE
PE Ratio
21.15
21.15
1Y Return
0.17%
0.17%
Buy Reco %
50.00
50.00
INFLUX Forecast
INFLUX Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
INFLUX
INFLUX
Income
Balance Sheet
Cash Flow
Annual Normal View
INFLUX Income Statement
INFLUX Income Statement
Annual Normal View
| Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 59.22 | 76.06 | 100.02 | 104.98 | — | ||||||
Raw Materials | 0.00 | 46.57 | 39.92 | 48.59 | 43.21 | — | ||||||
| Power & Fuel Cost | 0.43 | 0.67 | 0.99 | 1.27 | ||||||||
| Employee Cost | 3.20 | 4.62 | 6.44 | 7.79 | ||||||||
| Selling & Administrative Expenses | 1.51 | 2.71 | 3.46 | 3.72 | ||||||||
| Operating & Other expenses | 1.27 | 17.40 | 23.53 | 28.29 | ||||||||
EBITDA | 0.00 | 6.24 | 10.74 | 17.01 | 20.70 | — | ||||||
| Depreciation/Amortization | 0.00 | 0.12 | 0.94 | 1.85 | 2.82 | — | ||||||
| PBIT | 0.00 | 6.12 | 9.80 | 15.16 | 17.88 | — | ||||||
| Interest & Other Items | 0.00 | 0.04 | 0.06 | 0.22 | 0.01 | — | ||||||
| PBT | 0.00 | 6.08 | 9.74 | 14.94 | 17.87 | — | ||||||
| Taxes & Other Items | 0.00 | 1.57 | 2.54 | 3.80 | 4.51 | — | ||||||
| Net Income | 0.00 | 4.51 | 7.20 | 11.14 | 13.36 | — | ||||||
| EPS | 0.00 | 2.48 | 3.97 | 6.14 | 7.36 | — | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||
| Payout ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
INFLUX Company Updates
INFLUX Stock Peers
INFLUX Past Performance & Peer Comparison
INFLUX Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Influx Healthtech Ltd | 32.69 | 12.08 | — |
| Sun Pharmaceutical Industries Ltd | 38.03 | 5.73 | 0.92% |
| Torrent Pharmaceuticals Ltd | 67.73 | 17.05 | 0.84% |
| Cipla Ltd | 23.28 | 3.92 | 1.05% |
INFLUX Stock Price Comparison
Compare INFLUX with any stock or ETFCompare INFLUX with any stock or ETF
INFLUX
INFLUX Holdings
INFLUX Shareholdings
INFLUX Promoter Holdings Trend
INFLUX Promoter Holdings Trend
INFLUX Institutional Holdings Trend
INFLUX Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 2.61%
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 1.55%
INFLUX Shareholding Pattern
INFLUX Shareholding Pattern
INFLUX Shareholding History
INFLUX Shareholding History
Foreign Institutions
smallcases containing INFLUX stock
smallcases containing INFLUX stock
Looks like this stock is not in any smallcase yet.
INFLUX Events
INFLUX Events
INFLUX Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INFLUX has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
INFLUX Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INFLUX has not given any dividends in last 5 years
INFLUX Dividends
INFLUX Dividends
Hmm, looks like data is unavailable here. Please come back after some timeINFLUX Stock News & Opinions
INFLUX Stock News & Opinions
Articles & Videos
Corporate
Influx Healthtech to hold board meeting
Influx Healthtech will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Influx Healthtech AGM scheduled
Influx Healthtech announced that the 5th Annual General Meeting(AGM) of the company will be held on 9 September 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
NSE SME Influx Healthtech makes a strong debut
The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public offer (IPO) price. The stock was currently down 1.9% over its listing price. The counter hit a high of Rs 135.85 and a low of Rs 125.90. About 28.55 lakh shares of the company changed hands at the counter. Influx Healthtech's IPO was subscribed 187.31 times. The issue opened for bidding on 18 June 2025 and it closed on 20 June 2025. The price band of the IPO was fixed at Rs 91 to Rs 96 per share. The IPO of 61,00,800 equity shares comprised a fresh issue of 50,00,400 equity shares and offer for sale (OFS) of 11,00,400 equity shares. The promoter and promoter group shareholding diluted to 73.53% from 99.85% pre-issue. The company intends to utilize the net proceeds for funding capital expenditure requirements for setting up of manufacturing facility for nutraceutical division, funding capital expenditure requirements for setting up of manufacturing facility for veterinary food division, purchase of machineries for homecare and cosmetic division and general corporate expenses. Ahead of the Influx Healthtech on 17 June 2025, raised Rs 16.66 crore from anchor investors. The board has allotted 17.36 lakh shares at Rs 96 per share to 8 anchor investors. Influx Healthtech is a Mumbai-based, healthcare focused company specialising in contract manufacturing. Since its inception in 2020, the company has established itself as a reliable contract development and manufacturing organization (CDMO). The company offers comprehensive production services across a wide range of categories, including dietary and nutritional supplements, cosmetics, ayurvedic and herbal products, veterinary feed supplements, homecare products, active pharmaceutical ingredients (APIs), and finished dosage forms such as tablets, capsules and injectables. The company had a total workforce of 163 permanent employees on a payroll basis. The company recorded revenue from operations of Rs 104.85 crore and net profit of Rs 13.37 crore for the period ended 31 March 2025. Powered by Capital Market - Live
4 months agoCapital Market - Live
Pledged promoter holdings is insignificant